References
- Else M, Dearden CE, Matutes E, . Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol 2009;145:733–740.
- Chadha P, Rademaker AW, Mendiratta P, . Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood 2005;106: 241–246.
- Hisada M, Chen BE, Jaffe ES, . Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. J Natl Cancer Inst 2007;99: 215–222.
- Goodman GR, Burian C, Koziol JA, . Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003;21:891–896.
- Saven A, Burian C, Koziol JA, . Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998;92:1918–1926.
- Federico M, Zinzani PL, Frassoldati A, . Risk of second cancer in patients with hairy cell leukemia: long-term follow-up. J Clin Oncol 2002;20:638–646.
- Bastie JN, Cazals-Hatem D, Daniel MT, . Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4 + lymphocytopenia after treatment. Leuk Lymphoma 1999;35: 555–565.
- Seto S, Carrera CJ, Kubota M, . Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J Clin Invest 1985;75:377–83.
- Seymour J, Kurzrock R, Freireich E, . 2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4 + lymphocyte counts in patients with hairy cell leukemia. Blood 1994;83:2906–2911.
- Kluin-Nelemans J, Kester M, Melenhorst J, . Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 1996;87:3795–3802.
- Maloisel F, Benboubker L, Gardembas M, . Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients. Leukemia 2003;17: 45–51.
- Knecht H, Sarraj A, Delacretaz F, . Genotypic and phenotypic evidence of T-cell leukemia in a patient successfully treated by interferon-alpha for typical hairy cell leukemia. Leukemia 1991;5: 1031–1036.
- Lichty BD, Ackland-Snow J, Noble L, . Dysregulation of HOX11 by chromosome translocations in T-cell acute lymphoblastic leukemia: a paradigm for homeobox gene involvement in human cancer. Leuk Lymphoma 1995;16:209–215.
- Ferrara F, Scognamiglio M, Di Noto R, . Interstitial 9q deletion is associated with CD7 + acute leukemia of myeloid and T lymphoid lineage. Leukemia 1996;10:1990–1992.